Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danne, T.
Right arrow Articles by Jensen, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danne, T.
Right arrow Articles by Jensen, L. H.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 26:2359-2364, 2003
© 2003 by the American Diabetes Association, Inc.

Epidemiology/Health Services/Psychosocial Research
Original Article

A Comparison of Postprandial and Preprandial Administration of Insulin Aspart in Children and Adolescents With Type 1 Diabetes

Thomas Danne, MD1, Jan Aman, MD2, Edith Schober, MD3, Dorothee Deiss, MD4, Judith L. Jacobsen, MSC5, Hans Henrik Friberg, MSC5 and Lars Hein Jensen, MSC PHARM5 the ANA 1200 Study Group

1 Kinderkrankenhaus auf der Bult, Diabetes-Zentrum für Kinder und Jugendliche, Hannover, Germany
2 Department of Paediatrics, (Barn och Ungdomskliniken), Regional Hospital, Örebro, Sweden
3 Universitätsklinik für Kinder- und Jugendheilkunde, Wien, Austria
4 Klinik für Allgemeine Pädiatrie, Charité, Campus Virchow-Klinikum, Berlin, Germany
5 Novo Nordisk A/S, Bagsvaerd, Denmark

Address correspondence and reprint requests to Thomas Danne, MD, Kinderkrankenhaus auf der Bult, Diabetes-Zentrum für Kinder und Jugendliche, Janusz-Korczak-Allee 12, 30173 Hannover, Germany. E-mail: danne{at}hka.de

OBJECTIVE—The aim of this study was to compare the glycemic control of preprandial versus postprandial injections of the new rapid-acting insulin analogue aspart in children and adolescents with type 1 diabetes.

RESEARCH DESIGN AND METHODS—Forty-two children (aged 6–12 years) and 34 adolescents (13–17 years) were randomized to preprandial (immediately before meal start) and postprandial (immediately after a meal or a maximum of 30 min after meal start) treatment with insulin aspart (at least thrice daily) as part of a basal/bolus regimen in a multicenter study with an open labeled, two-period cross-over design (6-week periods). Of this group, 49% were boys, 55% were aged <=13 years, and duration of diabetes was 4.4 years (range 1.0–9.4).

RESULTS—Glycemic control for postprandial treatment was not worse than preprandial treatment as assessed by fructosamine week 0 vs. 6 (mean ± SD, preprandial 367 ± 74 vs. 378 ± 90 µmol/l; postprandial 383 ± 83 vs. 385 ± 77 µmol/l) and HbA1c (preprandial 7.9 ± 1.3 vs. 8.0 ± 1.5%; postprandial 8.0 ± 1.4 vs. 8.3 ± 1.5%, P = 0.14). The only statistically significant finding from the seven-point blood glucose profiles and derived parameters between preprandial and postprandial treatment was a lower postprandial glucose level 120 min after breakfast (mean ± SEM, -2.08 ± 0.74 mmol/l, P = 0.016). The relative risk of hypoglycemia (blood glucose <3.9 mmol/l) preprandially to postprandially was not significantly different (mean 1.1; 95% CI 0.91–1.35; P = 0.31). Overall treatment satisfaction was equally high for both regimens with both patients and parents.

CONCLUSIONS—Although preprandial administration of insulin aspart is generally preferable, this study shows that in children and adolescents, postprandial administration of insulin aspart is a safe and effective alternative.

Abbreviations: AE, adverse event • DTSQ, Diabetes Treatment Satisfaction Questionnaire • IAsp post, postprandial administration of insulin aspart • IAsp pre, preprandial administration of insulin aspart • PP, per protocol


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
T. Danne, K. Lange, and O. Kordonouri
New developments in the treatment of type 1 diabetes in children
Arch. Dis. Child., November 1, 2007; 92(11): 1015 - 1019.
[Full Text] [PDF]

Home page
 EDUCATION AND PRACTICEHome page
F. M Regan and D. B Dunger
Use of new insulins in children
Arch. Dis. Child. Ed. Pract., August 1, 2006; 91(2): ep47 - ep53.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
T. Danne, R. H. A. Becker, T. Heise, C. Bittner, A. D. Frick, and K. Rave
Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes
Diabetes Care, September 1, 2005; 28(9): 2100 - 2105.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
W. Kiess, K. Raile, A. Galler, and T. Kapellen
Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes: Response to Home et al.
Diabetes Care, October 1, 2004; 27(10): 2567 - 2568.
[Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
Other articles noted: 25 Jul 03 to 7 Nov 03
Evid. Based Nurs., January 1, 2004; 7(1): e1 - 1.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.